Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $11.2650 (-3.06%) ($11.2650 - $11.2650) on Fri. Mar. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.42% (three month average) | RSI | 24 | Latest Price | $11.2650(-3.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -0.1% a day on average for past five trading days. | Weekly Trend | FOLD declines -6.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) XBI(60%) IBB(57%) IWO(45%) IWM(44%) IWN(42%) | Factors Impacting FOLD price | FOLD will decline at least -1.21% in a week (0% probabilities). VXX(-19%) TBT(-16%) VIXM(-10%) UUP(-10%) BND(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.21% (StdDev 2.42%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.2(-101.78%) | Resistance Level | $12.31 | 5 Day Moving Average | $11.43(-1.44%) | 10 Day Moving Average | $11.62(-3.06%) | 20 Day Moving Average | $12.31(-8.49%) | To recent high | -17.5% | To recent low | 0% | Market Cap | $2.909b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |